Jennison Associates LLC Next Cure, Inc. Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$8.15 - $21.17 $3.8 Million - $9.87 Million	-466,364 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$21.19 - $40.2 $40,769 - $77,344	1,924 Added 0.41%	466,364 $10 Million
Q1 2020 May 06, 2020	BUY	$32.32 - $58.37 $11.8 Million - $21.3 Million	364,440 Added 364.44%	464,440 $17.2 Million
Q4 2019 Feb 07, 2020	BUY	$25.0 - $92.22 $2.5 Million - $9.22 Million	100,000 New	100,000 $5.63 Million

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $26.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.